JA Ledermann
JA Ledermann
Professor of medical oncology, UCL Cancer Institute
Verified email at ucl.ac.uk
Cited by
Cited by
A phase 3 trial of bevacizumab in ovarian cancer
TJ Perren, AM Swart, J Pfisterer, JA Ledermann, E Pujade-Lauraine, ...
New England Journal of Medicine 365 (26), 2484-2496, 2011
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer
J Ledermann, P Harter, C Gourley, M Friedlander, I Vergote, G Rustin, ...
New England Journal of Medicine 366 (15), 1382-1392, 2012
Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer
MR Mirza, BJ Monk, J Herrstedt, AM Oza, S Mahner, A Redondo, ...
New England Journal of Medicine 375 (22), 2154-2164, 2016
Ovarian cancer
GC Jayson, EC Kohn, HC Kitchener, JA Ledermann
The Lancet 384 (9951), 1376-1388, 2014
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised …
J Ledermann, P Harter, C Gourley, M Friedlander, I Vergote, G Rustin, ...
The lancet oncology 15 (8), 852-861, 2014
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
Icon and Ago Collaborators
The Lancet 361 (9375), 2099-2106, 2003
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up
N Colombo, C Creutzberg, F Amant, T Bosse, A González-Martín, ...
International Journal of Gynecologic Cancer 26 (1), 2016
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised …
E Pujade-Lauraine, JA Ledermann, F Selle, V Gebski, RT Penson, ...
The lancet oncology 18 (9), 1274-1284, 2017
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ...
The Lancet 390 (10106), 1949-1961, 2017
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
JA Ledermann, FA Raja, C Fotopoulou, A Gonzalez-Martin, N Colombo, ...
Annals of oncology 24, vi24-vi32, 2013
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
MT Seymour, TS Maughan, JA Ledermann, C Topham, R James, ...
The Lancet 370 (9582), 143-152, 2007
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
AM Oza, AD Cook, J Pfisterer, A Embleton, JA Ledermann, ...
The Lancet Oncology 16 (8), 928-936, 2015
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label …
RD James, R Glynne-Jones, HM Meadows, D Cunningham, AS Myint, ...
The lancet oncology 14 (6), 516-524, 2013
Guidelines for resection of colorectal cancer liver metastases
OJ Garden, M Rees, GJ Poston, D Mirza, M Saunders, J Ledermann, ...
Gut 55 (suppl 3), iii1-iii8, 2006
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer
GCE Stuart, H Kitchener, M Bacon, C Marth, T Thigpen, E Trimble
Int J Gynecol Cancer 21 (4), 750-5, 2011
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC …
T Ruers, C Punt, F Van Coevorden, J Pierie, I Borel-Rinkes, ...
Annals of Oncology 23 (10), 2619-2626, 2012
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo …
JA Ledermann, P Harter, C Gourley, M Friedlander, I Vergote, G Rustin, ...
The lancet oncology 17 (11), 1579-1589, 2016
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
J Northover, R Glynne-Jones, D Sebag-Montefiore, R James, H Meadows, ...
British journal of cancer 102 (7), 1123-1128, 2010
PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
JM Lee, JA Ledermann, EC Kohn
Annals of oncology 25 (1), 32-40, 2014
Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial
T Ruers, F Van Coevorden, CJA Punt, JPEN Pierie, I Borel-Rinkes, ...
JNCI: Journal of the National Cancer Institute 109 (9), 2017
The system can't perform the operation now. Try again later.
Articles 1–20